Expression changes of c-Fos and D1R/p-ERK1/2 signal pathways in nucleus accumbens of rats after ketamine abuse

Biochem Biophys Res Commun. 2022 Nov 12:629:183-188. doi: 10.1016/j.bbrc.2022.08.091. Epub 2022 Sep 5.

Abstract

Ketamine is a commonly used dissociative anesthetic in clinical applications. However, the abuse potential has posted limits to its use and the mechanism remains to be studied. We aimed to investigate the changes of dopamine D1 receptors (D1R), phosphorylation of extracellular-regulated protein kinase 1/2 (p-ERK1/2), and c-Fos expression in the nucleus accumbens (NAc) of ketamine abuse rats. Ketamine induced severe anxiety in rats, as shown by an open field test. Nissl staining demonstrated clearly different morphologies between neurons of ketamine abuse rats and normal rats. The molecular expression changes were examined using immunohistochemistry assay and western blotting. D1R, p-ERK1/2, and c-Fos were significantly highly-expressed in NAc during ketamine exposure and were decreased by D1R antagonist SCH23390 and MAPK kinases inhibitor U0126. Taken together, the results suggest that ketamine abuse may induce the overexpression of c-Fos in NAc by up-regulating the expression of D1R and p-ERK1/2.

Keywords: Dopamine D1 receptors; Ketamine; Nucleus accumbens; c-Fos; p-ERK 1/2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Dissociative / pharmacology
  • Animals
  • Ketamine* / pharmacology
  • MAP Kinase Signaling System / physiology
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Nucleus Accumbens* / metabolism
  • Proto-Oncogene Proteins c-fos / metabolism
  • Rats
  • Receptors, Dopamine D1 / metabolism
  • Signal Transduction

Substances

  • Anesthetics, Dissociative
  • Proto-Oncogene Proteins c-fos
  • Receptors, Dopamine D1
  • Ketamine
  • Mitogen-Activated Protein Kinase Kinases